Hookipa Pharma Valuation
| HOOK Stock | USD 1.06 0.03 2.91% |
Today, the firm appears to be undervalued. Hookipa Pharma retains a regular Real Value of $1.24 per share. The prevalent price of the firm is $1.06. Our model calculates the value of Hookipa Pharma from evaluating the firm fundamentals such as Shares Outstanding of 9.93 M, return on equity of -1.06, and Return On Asset of -0.45 as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Hookipa Pharma's valuation include:
Price Book 0.4428 | Enterprise Value | Enterprise Value Ebitda 0.4569 | Price Sales 1.3977 | Enterprise Value Revenue 1.9077 |
Undervalued
Today
Please note that Hookipa Pharma's price fluctuation is risky at this time. Calculation of the real value of Hookipa Pharma is based on 3 months time horizon. Increasing Hookipa Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Hookipa Pharma's intrinsic value may or may not be the same as its current market price of 1.06, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.06 | Real 1.24 | Target 2.0 | Hype 1.06 |
The intrinsic value of Hookipa Pharma's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Hookipa Pharma's stock price.
Estimating the potential upside or downside of Hookipa Pharma helps investors to forecast how Hookipa stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Hookipa Pharma more accurately as focusing exclusively on Hookipa Pharma's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Hookipa Pharma's intrinsic value based on its ongoing forecasts of Hookipa Pharma's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Hookipa Pharma's closest peers.
Hookipa Pharma Cash |
|
Hookipa Pharma Total Value Analysis
Hookipa Pharma is currently estimated to have valuation of (20.98 M) with market capitalization of 13.07 M, debt of 875 K, and cash on hands of 117.92 M. The negative valuation of Hookipa Pharma may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Hookipa Pharma fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(20.98 M) | 13.07 M | 875 K | 117.92 M |
Hookipa Pharma Investor Information
The company has price-to-book (P/B) ratio of 0.44. Some equities with similar Price to Book (P/B) outperform the market in the long run. Hookipa Pharma recorded a loss per share of 4.83. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 10th of July 2024. Based on the key measurements obtained from Hookipa Pharma's financial statements, Hookipa Pharma may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter.Hookipa Pharma Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Hookipa Pharma has an asset utilization ratio of 53.24 percent. This suggests that the Company is making $0.53 for each dollar of assets. An increasing asset utilization means that Hookipa Pharma is more efficient with each dollar of assets it utilizes for everyday operations.Hookipa Pharma Profitability Analysis
Based on the key profitability measurements obtained from Hookipa Pharma's financial statements, Hookipa Pharma may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in March. Profitability indicators assess Hookipa Pharma's ability to earn profits and add value for shareholders.Net Loss | First Reported 2018-03-31 | Previous Quarter -15.4 M | Current Value -1.8 M | Quarterly Volatility 8.1 M |
For Hookipa Pharma profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Hookipa Pharma to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Hookipa Pharma utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Hookipa Pharma's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Hookipa Pharma over time as well as its relative position and ranking within its peers.
Hookipa Pharma Earnings per Share Projection vs Actual
By analyzing Hookipa Pharma's earnings estimates, investors can diagnose different trends across Hookipa Pharma's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Hookipa Pharma is based on EPS before non-recurring items and includes expenses related to employee stock options.Hookipa Pharma Ownership Allocation
The market capitalization of Hookipa Pharma is $13.07 Million. Roughly 87.72 (percent) of Hookipa Pharma outstanding shares are held by general public with 0.12 % owned by insiders and only 12.16 pct. by outside corporations. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.Hookipa Pharma Profitability Analysis
The company reported the previous year's revenue of 43.95 M. Net Loss for the year was (43.5 M) with loss before overhead, payroll, taxes, and interest of (50.47 M).About Hookipa Pharma Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Hookipa Pharma. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Hookipa Pharma based exclusively on its fundamental and basic technical indicators. By analyzing Hookipa Pharma's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Hookipa Pharma's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Hookipa Pharma. We calculate exposure to Hookipa Pharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Hookipa Pharma's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 47.4 M | 49.7 M | |
| Pretax Profit Margin | (0.89) | (0.94) | |
| Operating Profit Margin | (1.05) | (1.11) | |
| Net Loss | (0.89) | (0.94) | |
| Gross Profit Margin | 0.84 | 0.89 |
Hookipa Pharma Current Valuation Indicators
Hookipa Pharma's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Hookipa Pharma's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Hookipa Pharma, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Hookipa Pharma's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Hookipa Pharma's worth.When determining whether Hookipa Pharma is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Hookipa Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Hookipa Pharma Stock. Highlighted below are key reports to facilitate an investment decision about Hookipa Pharma Stock: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hookipa Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. For more information on how to buy Hookipa Stock please use our How to buy in Hookipa Stock guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hookipa Pharma. Market participants price Hookipa higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Hookipa Pharma assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (4.83) | Revenue Per Share | Quarterly Revenue Growth (0.94) | Return On Assets | Return On Equity |
Investors evaluate Hookipa Pharma using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Hookipa Pharma's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Hookipa Pharma's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Hookipa Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hookipa Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Hookipa Pharma's market price signifies the transaction level at which participants voluntarily complete trades.